Table 3.

Erythrocyte elongation index (EI) (%) in the shear stress range 0.6–12 Pa for different treatment groups, n = 23.

Shear stress
	0.6 Pa	1.2 Pa	3 Pa	6 Pa	12 Pa
Healthy controls	5.87 ± 0.72*	14.37 ± 0.61*	29.08 ± 0.79*	39.19 ± 1.02*	45.93 ± 0.85*
Diabetes patients	4.38 ± 0.63	11.77 ± 0.49	26.01 ± 0.60	35.48 ± 0.84	43.34 ± 0.92
C-peptide	5.40 ± 0.82*	14.11 ± 0.85*	28.34 ± 1.58*	39.07 ± 1.46*	45.82 ± 1.43*
HP	5.77 ± 0.81*	14.18 ± 1.17*	28.61 ± 1.37*	38.49 ± 1.62*	45.82 ± 1.81*
PP	6.12 ± 0.93*	14.02 ± 1.37*	28.23 ± 1.46*	38.85 ± 1.54*	45.20 ± 1.74*
MF	4.42 ± 0.89	11.39 ± 1.07	25.82 ± 1.24	35.79 ± 0.98	43.39 ± 1.17
SCR	4.10 ± 0.91	11.25 ± 1.07	25.58 ± 1.07	35.64 ± 0.91	43.48 ± 1.00

*P < .01 versus type 1 diabetes patients.